Results 11 to 20 of about 92,765 (376)

Nose to Brain Delivery of Phenytoin Sodium Loaded Nano Lipid Carriers: Formulation, Drug Release, Permeation and In Vivo Pharmacokinetic Studies

open access: yesPharmaceutics, 2021
An acute epileptic seizure is a seizure emergency fatal condition that requires immediate medical attention. IV phenytoin sodium remains the second line therapeutic agent for the immediate treatment of status epilepticus.
Sreeja C. Nair   +2 more
doaj   +2 more sources

Phenytoin inhibits necroptosis [PDF]

open access: yesCell Death & Disease, 2018
Receptor-interacting protein kinases 1 and 3 (RIPK1/3) have best been described for their role in mediating a regulated form of necrosis, referred to as necroptosis.
Anne von Mässenhausen   +27 more
semanticscholar   +4 more sources

Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series

open access: yesPharmaceuticals, 2018
BACKGROUND: Neuropathic pain can be disabling, and is often difficult to treat. Within a year, over half of all patients stop taking their prescribed neuropathic pain medication, which is most probably due to side effects or disappointing analgesic ...
David J. Kopsky, Jan M. Keppel Hesselink
doaj   +2 more sources

Extracorporeal Treatment in Phenytoin Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup [PDF]

open access: yesAmerican Journal of Kidney Diseases, 2016
The Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup conducted a systematic literature review using a standardized process to develop evidence-based recommendations on the use of extracorporeal treatment (ECTR) in patients with phenytoin ...
Anseeuw, Kurt   +7 more
core   +2 more sources

Phenytoin-induced Ogilvie syndrome: A rare case report [PDF]

open access: yesSAGE Open Medical Case Reports
Phenytoin is a widely prescribed antiepileptic drug that is associated with various adverse effects, but gastrointestinal manifestations are rare. Therapeutic drug monitoring is essential for ensuring safe and effective dosing by measuring the drug ...
Joel Sabu   +2 more
doaj   +2 more sources

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C9 and HLA-B Genotype and Phenytoin Dosing [PDF]

open access: yesClinical pharmacology and therapy, 2014
Phenytoin is a widely used antiepileptic drug with a narrow therapeutic index and large inter-patient variability partly due to genetic variations in CYP2C9.
Callaghan, J. Thomas   +7 more
core   +4 more sources

Hepatoprotective potential of N-acetyl cysteine in rats with phenytoin induced liver injury [version 1; peer review: 2 approved] [PDF]

open access: yesF1000Research
Background Phenytoin is an anticonvulsant medication that is effective in treating various seizure disorders. It is mostly metabolized by the liver, which increases the risk of PHT-induced hepatotoxicity. Aims This study aimed to assess the effectiveness
Fadhaa Abdulameer Ghafil   +5 more
doaj   +2 more sources

Phenytoin: A Guide to Therapeutic Drug Monitoring

open access: yesProceedings of Singapore Healthcare, 2013
Therapeutic drug monitoring of phenytoin is carried out to ensure effective and safe levels. Some of the factors complicating phenytoin dosing include a narrow therapeutic window, high degree of protein binding, and nonlinear pharmacokinetics.
Melissa Faye Wu BSc (Pharm) (Hons)   +1 more
doaj   +2 more sources

Phenytoin induced Chorea: commonly used antiepileptic drug causing a rare movement disorder [PDF]

open access: yesAsia Pacific Journal of Medical Toxicology, 2020
Background: Phenytoin, a commonly prescribed antiepileptic drug, causes side effects like ataxia, tremor, hirsutism, gum hyperplasia, insomnia, confusion, headache and vertigo when used for longer duration.
Rambhupal NAGIREDDY   +3 more
doaj   +1 more source

Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning

open access: yesFrontiers in Neurology, 2022
BackgroundPhenytoin is widely used as primary seizure prophylaxis in hematopoietic stem cell transplantation in patients undergoing myeloablative conditioning with busulfan. Because of the negative side effects of phenytoin, we abandoned phenytoin use in
R. S. Germeraad   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy